Table 1. Details of Yes structure and processing methods of Enamine library by different groups to select 120 compounds.
Group ID | Modeling of Yes structure |
Processing method of Enamine Library |
|||
---|---|---|---|---|---|
3D structure prediction methods/tools | Template(s) PDB ID | Filter class | Activesa | Decoys | |
1 | FAMS | 1Y57 | LB → SBb | Co-crystalized ligands in PDB | — |
2 | Prime | 2SRC | LBa LB&SB | PubChem BioAssay (AID 686947) | — |
3 | Modeller | 1Y57 | LBa → SB LBa LBa&SB | Pubchem BioAssay (AID686946) | — |
4 | — | — | LBc | Kinase SARfari | — |
5 | Modeller | Close homologs | LB&SB | Co-crystalized ligands in PDB | — |
6 | — | — | LBa | Pubchem BioAssay (AID686947) | — |
7 | Prime | 3G5D | SB | Co-crystalized dasatinib in PDB (3G5D) | — |
8 | — | — | LBa | Pubchem (AID686947) | — |
9 | Prime | 2SRC | SB | BindingDB | DUD-E |
10 | Modeller | 1FMK | SB → LBa | Dasatinib, bosutinib & saracatinib BindingDB < 500 nM | BindingDB ( > 500 nM) |
aYes specific/Src kinase family inhibitors reported using experimental methods.
bLigands collected from cocrystallized structures that show more sequence similarity with Yes (25 ligands for group 1 and 70 for group 2).
cDescriptor of residue surrounding ATP binding pocket was also used. LB, SB and ML denote ligand based, structure base and machine learning approaches used for initial filtering of 2.2 million Enamine library compounds.